Es sind 8+ Publikationen für dieses Produkt verfügbar. Der Maus Monoklonal anti-LAG3 Antikörper wird verwendet zum Nachweis von LAG3 in Proben von Human. Er wurde validiert für WB, IHC, ICC, IP, FACS und Func.
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
In PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Short Term Storage: +4°C Long Term Storage: -20°C Stable for at least 1 year after receipt when stored at -20°C.
Haltbarkeit
12 months
Triebel, Hacene, Pichon: "A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors." in: Cancer letters, Vol. 235, Issue 1, pp. 147-53, (2006) (PubMed).
Maçon-Lemaître, Triebel: "The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells." in: Immunology, Vol. 115, Issue 2, pp. 170-8, (2005) (PubMed).
Di Carlo, Cappello, Sorrentino, DAntuono, Pellicciotta, Giovarelli, Forni, Musiani, Triebel: "Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway." in: The Journal of pathology, Vol. 205, Issue 1, pp. 82-91, (2004) (PubMed).
Demeure, Wolfers, Martin-Garcia, Gaulard, Triebel: "T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts." in: European journal of cancer (Oxford, England : 1990), Vol. 37, Issue 13, pp. 1709-18, (2001) (PubMed).
Huard, Mastrangeli, Prigent, Bruniquel, Donini, El-Tayar, Maigret, Dréano, Triebel: "Characterization of the major histocompatibility complex class II binding site on LAG-3 protein." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 11, pp. 5744-9, (1997) (PubMed).
Huard, Gaulard, Faure, Hercend, Triebel: "Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand." in: Immunogenetics, Vol. 39, Issue 3, pp. 213-7, (1994) (PubMed).
Baixeras, Huard, Miossec, Jitsukawa, Martin, Hercend, Auffray, Triebel, Piatier-Tonneau: "Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens." in: The Journal of experimental medicine, Vol. 176, Issue 2, pp. 327-37, (1992) (PubMed).
Target
LAG3
(Lymphocyte-Activation Gene 3 (LAG3))
Andere Bezeichnung
LAG-3
Hintergrund
Lymphocyte activation gene 3 (LAG-3, CD223) plays an important role in negatively regulating T cell proliferation, function and homeostasis. It is required for maximal natural and induced regulatory T cell (Treg) function. LAG-3 is closely related to the T cell co-receptor CD4 and binds to MHC class II molecules but with a significantly higher affinity than CD4.